A Multi-center, Open Label, Random Clinical Trial of Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2018
Price : $35 *
At a glance
- Drugs Celecoxib (Primary) ; Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 13 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Feb 2017.
- 13 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Feb 2017.
- 13 Apr 2016 Status changed from recruiting to active, no longer recruiting.